Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 17, 2019
Seven Bridges has announced the availability of the Seven Bridges Automation Tools and Services.
read more
Seven Bridges announced the successful completion of independent examinations for SOC 2 Type 2, SOC 3 and HIPAA.
read more
Tuesday, November 15, 2016
Seven Bridges, a biomedical data analysis company, and SolveBio have nnounced the integration of their complementary platforms for genomic data analysis. The integration of Seven Bridges’ platform for cloud-based biomedical data analysis with ...
read more
Wednesday, January 06, 2021
Servier and X-Chem announced a partnership to identify and develop novel small molecules for the treatment of neurological disorders.
read more
Servier and Yposkesi announced they have signed a manufacturing service agreement.
read more
The Oracle Health Sciences' Clinical One platform has been selected by Servier to make its vision of a next-generation clinical trial management environment a reality. To start and manage clinical trials is a lengthy and regulated process that ...
read more
Servier announced the launch of InnoPreP, a new preparative chromatography service offered under its contract development and manufacturing business.
read more
Servier has finalized the previously announced acquisition of Shire's oncology branch after obtaining regulatory clearance.
read more
Servier has entered into a collaborative study with Harvard University researchers to explore a new avenue for the treatment of type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).
read more
Servier CDMO announced the company has invested $7.5 million in intensified technology including continuous chromatography with SMB and SFC with solvent recycling of up to 90% to lower environmental impact.
read more
Servier and Miragen Therapeutics announced they have extended their research collaboration through September 2019.
read more
Wednesday, January 08, 2020
Pfenex announced that Serum Institute achieved WHO prequalification for Pneumosil, a 10-valent pneumococcal conjugate vaccine.
read more
SeraNovo has signed a second License Agreement with Carna Biosciences.
read more
Monday, September 09, 2024
Serán BioScience, LLC announced that it has completed an expansion to increase the number of process manufacturing suites at its facility in Bend, Oregon, from 6 to 14, adding approximately 130% more CGMP clinical manufacturing capacity.
read more
Wednesday, October 22, 2025
Serán BioScience has announced an expansion of its commercial manufacturing footprint with the development of a new 100,000-square-foot campus in Bend, Oregon.
read more